Literature DB >> 9197367

Lethal graft-versus-host disease after simultaneous kidney-pancreas transplantation.

P Kimball1, J Ham, M Eisenberg, A King, R Fisher, C Rhodes, M Posner.   

Abstract

BACKGROUND: This case report is the first documentation of the occurrence and potential source of lethal graft-versus-host disease (GVHD) after simultaneous kidney-pancreas transplantation. The patient was a 27-year-old African-American male who received an ABO-compatible, five HLA antigen-mismatched kidney-pancreas transplant from a 17-year-old African-American female donor, who died after childbirth.
METHODS: Preoperative crossmatches using lymphocytotoxicity and flow cytometry were negative. The patient received four blood transfusions within 10 days of transplantation. Immunosuppression consisted of OKT3 induction, and then cyclosporine, azathioprine, and corticosteroids.
RESULTS: On postoperative day (POD) 9, the patient became febrile, and leukocytopenia and pancytopenia developed. Immunosuppression was reduced and granulocyte colony-stimulating factor was begun. Cultures were negative, interleukin 6 and interleukin 8 levels were elevated, and a cutaneous rash appeared on POD 18. A skin biopsy demonstrated dermatitis with focal epidermal necrosis consistent with GVHD. In an attempt to identify the source of GVHD, variable-number tandem repeat analysis fingerprinting was performed with DNA from donor splenocytes, from the skin biopsy, as well as from the patient's buccal mucosa. The skin biopsy showed a mixed variable-number tandem repeat analysis type containing DNA fragments matching the recipient and donor. Blood donors were excluded as a source because they were serologically different from the organ donor. The patient developed liver abnormalities and died from multiorgan failure on POD 22.
CONCLUSIONS: We speculate that carryover of passenger donor lymphocytes within the transplanted organ were responsible for GVHD. Furthermore, donor traits such as sexual mismatching, African-American race, and alloimmune status may be important potential risk factors for GVHD.

Entities:  

Mesh:

Year:  1997        PMID: 9197367     DOI: 10.1097/00007890-199706150-00025

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  Dermatologic manifestations of solid organ transplantation-associated graft-versus-host disease: A systematic review.

Authors:  Grace Y Kim; Leah A Schmelkin; Mark D P Davis; Rokea A El-Azhary; Ann M Farrell; Alexander Meves; Julia S Lehman
Journal:  J Am Acad Dermatol       Date:  2017-12-27       Impact factor: 11.527

2.  100 multivisceral transplants at a single center.

Authors:  Andreas G Tzakis; Tomoaki Kato; David M Levi; Werviston Defaria; Gennaro Selvaggi; Debbie Weppler; Seigo Nishida; Jang Moon; Juan R Madariaga; Andre I David; Jeffrey J Gaynor; John Thompson; Erick Hernandez; Enrique Martinez; G Patricia Cantwell; Jeffrey S Augenstein; Anthony Gyamfi; Ernesto A Pretto; Lorraine Dowdy; Panagiotis Tryphonopoulos; Phillip Ruiz
Journal:  Ann Surg       Date:  2005-10       Impact factor: 12.969

Review 3.  Acute graft-versus-host disease following simultaneous pancreas-kidney transplantation: report of a case.

Authors:  Sadaki Asari; Ippei Matsumoto; Hirochika Toyama; Makoto Shinzeki; Tadahiro Goto; Masaki Tanaka; Sachiyo Shirakawa; Hironori Yamashita; Tetsuo Ajiki; Takumi Fukumoto; Yonson Ku
Journal:  Surg Today       Date:  2014-11-06       Impact factor: 2.549

4.  Graft-versus-host disease after simultaneous pancreas-kidney transplantation.

Authors:  Juhan Lee; Myoung Soo Kim; Kyu Ha Huh; Dong Jin Joo; Jae Geun Lee; Soon Il Kim
Journal:  Korean J Transplant       Date:  2020-03-31

5.  Graft-versus-Host Disease after Living-Unrelated Kidney Transplantation.

Authors:  N Zacharias; M H Gallichio; D J Conti
Journal:  Case Rep Transplant       Date:  2014-04-09

6.  Graft-Versus-Host Disease After Pancreatic Transplantation.

Authors:  Saad Saffo; Chengwei Peng; Nour Kibbi; Natalie Patel; Marie E Robert; Evelyn Adekolu; William S Asch; Mayra Sanchez
Journal:  ACG Case Rep J       Date:  2019-09-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.